Darren Lynch MD in Northampton, Massachusetts

Medical School: Georgetown University School Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Darren Lynch MD is listed as: General Practice
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 28
PAC (PECOS ID)#: 7810980307
NPI #: 1922087832
NPI Created On: 01/10/2006
NPI Last Updated Listed as: 06/10/2020
Primary Taxonomy Code: 207Q00000X
License Number:
219836
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Ige (immune system protein) level
2. Thyroxine (thyroid chemical) measurement
3. Blood test, thyroid stimulating hormone (tsh)
4. Thyroid hormone, t3 measurement
5. Measurement of antibody (ige) to allergic substance
6. Injection of allergenic extracts into skin for immediate reaction analysis
7. Injection of incremental dosages of allergen
8. Injection of incremental dosages of allergen, 2 or more injections
9. Preparation and provision of single or multiple antigens for allergen immunotherapy
10. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
11. New patient office or other outpatient visit, typically 45 minutes
12. New patient office or other outpatient visit, typically 60 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Established patient office or other outpatient, visit typically 40 minutes
16. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.